115 related articles for article (PubMed ID: 1980465)
1. Biliary excretion of H2-receptor antagonists.
Klotz U; Walker S
Eur J Clin Pharmacol; 1990; 39(1):91-2. PubMed ID: 1980465
[TBL] [Abstract][Full Text] [Related]
2. An Efficient Ion-Pair Liquid Chromatographic Method for the Determination of Some H2 Receptor Antagonists.
Elshaboury SR; Mohamed NA; Ahmed S; Farrag S
J Chromatogr Sci; 2016 Mar; 54(3):419-28. PubMed ID: 26538490
[TBL] [Abstract][Full Text] [Related]
3. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
5. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
[TBL] [Abstract][Full Text] [Related]
7. Short report: a comparative study of the interaction between antacid and H2-receptor antagonists.
Sullivan TJ; Reese JH; Jauregui L; Miller K; Levine L; Bachmann KA
Aliment Pharmacol Ther; 1994 Feb; 8(1):123-6. PubMed ID: 7910488
[TBL] [Abstract][Full Text] [Related]
8. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
9. Saturable transport of H2-antagonists ranitidine and famotidine across Caco-2 cell monolayers.
Lee K; Thakker DR
J Pharm Sci; 1999 Jul; 88(7):680-7. PubMed ID: 10393565
[TBL] [Abstract][Full Text] [Related]
10. Extremely early onset of ranitidine action on human histamine H2 receptors expressed in HEK293 cells.
Fukushima Y; Ishikawa T; Saitoh T; Tateishi K; Ogihara T; Fujishiro M; Shojima N; Honda M; Kushiyama A; Anai M; Sakoda H; Ono H; Onishi Y; Otsuka H; Katagiri H; Nagai R; Omata M; Asano T
Digestion; 2003; 68(2-3):145-52. PubMed ID: 14671421
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopic interaction studies of H2 receptor antagonists with levocetirizine.
Mehboob S; Mehboob M; Saleem DM; Mehjabeen -; Tariq Rafi SM; Khan H; Jahan N; Owais F; Batool F; Sultana N
Pak J Pharm Sci; 2021 May; 34(3(Special)):1283-1287. PubMed ID: 34602401
[TBL] [Abstract][Full Text] [Related]
12. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure.
Lameire N; Rosenkranz B; Brockmeier D
Scand J Gastroenterol Suppl; 1988; 146():100-10. PubMed ID: 2906455
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity labeling of the anionic sites in Caco-2 cells mediating saturable transport of hydrophilic cations ranitidine and famotidine.
Bourdet DL; Lee K; Thakker DR
J Med Chem; 2004 May; 47(11):2935-8. PubMed ID: 15139772
[TBL] [Abstract][Full Text] [Related]
15. Measurement of unbound ranitidine in blood and bile of anesthetized rats using microdialysis coupled to liquid chromatography and its pharmacokinetic application.
Huang SM; Tsai TR; Yeh PH; Tsai TH
J Chromatogr A; 2005 May; 1073(1-2):297-302. PubMed ID: 15909533
[TBL] [Abstract][Full Text] [Related]
16. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
Koch KM; Kerr BM; Gooding AE; Davis IM
Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two compartmental models for describing ranitidine's plasmatic profiles.
Schaiquevich P; Niselman A; Rubio M
Pharmacol Res; 2002 May; 45(5):399-405. PubMed ID: 12123628
[TBL] [Abstract][Full Text] [Related]
19. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
20. Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humans.
Reynolds KS; Song MH; Heizer WD; Burns CB; Sica DA; Brouwer KL
Pharm Res; 1998 Aug; 15(8):1281-5. PubMed ID: 9706062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
